| RS774010006 |
SGSH
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS774011311 |
TMEM67
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS774011358 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS774013796 |
POMK
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS774013935 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS774014588 |
HPDL
|
Health Risk |
Pathogenic |
Spastic paraplegia, Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities |
| RS774015258 |
CASP8
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS774015430 |
DLL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS774015502 |
RCBTB1
|
Health Risk |
Likely pathogenic |
— |
| RS774016801 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS77401687 |
BLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 11, BLK-related disorder |
| RS774016937 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS774018511 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS774018674 |
CRELD1
|
Health Risk |
Pathogenic |
Atrioventricular septal defect, susceptibility to |
| RS774019483 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS774020236 |
NDUFB9
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS774020682 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS774022115 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS774022852 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Genitopatellar syndrome, Inborn genetic diseases |
| RS774024734 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS774024906 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS774026652 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS774026720 |
KCTD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive myoclonic epilepsy type 3, Progressive myoclonic epilepsy type 3 |
| RS774027004 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS774027102 |
NCF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Granulomatous disease, chronic |
| RS774027595 |
TTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyloidosis, hereditary systemic 1 |
| RS774028311 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS774028495 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS774029027 |
PNPLA6
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS774029071 |
PSAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Sphingolipid activator protein 1 deficiency, Inborn genetic diseases |
| RS774029159 |
PIEZO2
|
Health Risk |
Likely pathogenic |
— |
| RS774029336 |
GALNT12
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS774030578 |
AGXT
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hyperoxaluria, type I |
| RS774030917 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS774032338 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS774032732 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS774034198 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, arthrochalasia type |
| RS774034389 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS774034606 |
F12
|
Health Risk |
Pathogenic |
Hereditary angioedema type 3, Hereditary angioedema type 3 |
| RS774035109 |
BBS12
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 12, Bardet-Biedl syndrome 12 |
| RS774035439 |
DDX54
|
Health Risk |
Likely pathogenic |
Intellectual disability, Neurodevelopmental delay |
| RS774035449 |
STIL
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS774035582 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 2, Ullrich congenital muscular dystrophy 2 |
| RS774037351 |
HPS5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS774037693 |
PIGV
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS774038272 |
SLCO2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS774039277 |
SLC6A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperekplexia 3, Hyperekplexia 3 |
| RS774039786 |
DOCK7
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 23 |
| RS774041089 |
ALDH5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Succinate-semialdehyde dehydrogenase deficiency, Succinate-semialdehyde dehydrogenase deficiency |
| RS774041613 |
CYP11B2
|
Health Risk |
Pathogenic |
Corticosterone 18-monooxygenase deficiency, Corticosterone methyloxidase type 2 deficiency |
| RS774043076 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Mitochondrial complex II deficiency |
| RS774043430 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS774044026 |
FREM1
|
Health Risk |
Likely pathogenic |
— |
| RS774044430 |
DGAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS774044532 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS774044758 |
ZNF341
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS774045142 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Osteogenesis imperfecta type I |
| RS774045741 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Idiopathic generalized epilepsy |
| RS774045808 |
LAMB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pierson syndrome, LAMB2-related disorder |
| RS774046285 |
ABCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS774046373 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy |
| RS774047299 |
ALDH18A1
|
Health Risk |
Conflicting classifications of pathogenicity |
ALDH18A1-related de Barsy syndrome, Cutis laxa |
| RS774047416 |
BSND
|
Health Risk |
Pathogenic |
— |
| RS774047474 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS774047625 |
ERCC8
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 1, Cockayne syndrome |
| RS774047684 |
TRMU
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Aminoglycoside-induced deafness |
| RS774047700 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, DYSF-related disorder |
| RS774048414 |
CAPN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS774048743 |
CAPN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS774048847 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 1, Fraser syndrome 1 |
| RS774049520 |
TMEM222
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with motor and speech delay and behavioral abnormalities, Neurodevelopmental disorder with motor and speech delay and behavioral abnormalities |
| RS774049893 |
ACOX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Acyl-CoA oxidase deficiency, ACOX1-related disorder |
| RS774050795 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS774051471 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS774052068 |
BTD
|
Health Risk |
Conflicting classifications of pathogenicity |
Biotinidase deficiency, BTD-related disorder |
| RS774052186 |
DONSON
|
Health Risk |
Pathogenic |
Meier-Gorlin syndrome, Meier-Gorlin syndrome |
| RS774054025 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Inborn genetic diseases |
| RS774054592 |
CHRNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS774054837 |
RAB7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2B, Charcot-Marie-Tooth disease type 2B |
| RS774055207 |
SRCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS774055989 |
DSCAML1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS774056037 |
TOE1
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 7, Pontocerebellar hypoplasia type 7 |
| RS774056663 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Nonsyndromic Deafness, Usher syndrome |
| RS774057025 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS774059974 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Short QT syndrome type 2, Long QT syndrome 1 |
| RS774060871 |
MYO16
|
Health Risk |
Likely pathogenic |
MYO16-associated developmental delay, MYO16-associated developmental delay |
| RS774060880 |
PIK3CG
|
Health Risk |
Pathogenic |
Immunodeficiency 97 with autoinflammation, Immunodeficiency 97 with autoinflammation |
| RS774061491 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoinflammatory syndrome, Familial Mediterranean fever |
| RS774061725 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS774063464 |
ERCC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum group B, Xeroderma pigmentosum group B |
| RS774064952 |
MOS
|
Health Risk |
Pathogenic |
Oocyte/zygote/embryo maturation arrest 20, Oocyte/zygote/embryo maturation arrest 20 |
| RS774064976 |
KDM1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS774065012 |
DSP
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 8, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS774066804 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS774067157 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS774068079 |
TRDN
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 5, Cardiovascular phenotype |
| RS774068411 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS774068657 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Aortic valve disease 1 |
| RS774068671 |
PHKB
|
Health Risk |
Pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS774068992 |
MANBA
|
Health Risk |
Conflicting classifications of pathogenicity |
Beta-D-mannosidosis, Beta-D-mannosidosis |